Shares of iShares iBonds Dec 2032 Term Corporate ETF (NYSEARCA:IBDX – Get Free Report) reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $24.77 and last traded at $24.78, with a volume of 74312 shares. The stock had previously closed at $24.80.
iShares iBonds Dec 2032 Term Corporate ETF Trading Down 0.8%
The company has a 50 day simple moving average of $24.93 and a 200 day simple moving average of $25.17.
Institutional Trading of iShares iBonds Dec 2032 Term Corporate ETF
Institutional investors have recently made changes to their positions in the company. Ballast Advisors LLC acquired a new position in iShares iBonds Dec 2032 Term Corporate ETF in the 1st quarter valued at $30,000. Ascentis Independent Advisors purchased a new position in iShares iBonds Dec 2032 Term Corporate ETF in the 1st quarter valued at $88,000. Bogart Wealth LLC boosted its stake in iShares iBonds Dec 2032 Term Corporate ETF by 115.2% during the 1st quarter. Bogart Wealth LLC now owns 4,721 shares of the company’s stock worth $119,000 after purchasing an additional 2,527 shares during the last quarter. Jupiter Wealth Management LLC acquired a new stake in iShares iBonds Dec 2032 Term Corporate ETF during the 2nd quarter worth $130,000. Finally, Trust Co. of Vermont purchased a new stake in shares of iShares iBonds Dec 2032 Term Corporate ETF during the second quarter worth $152,000.
About iShares iBonds Dec 2032 Term Corporate ETF
The iShares iBonds Dec 2032 Term Corporate ETF (IBDX) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a Bloomberg index of USD-denominated, investment grade corporate bonds maturing between January 1, 2032 and December 15, 2032. IBDX was launched on Jun 28, 2022 and is managed by BlackRock.
Further Reading
- Five stocks we like better than iShares iBonds Dec 2032 Term Corporate ETF
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for iShares iBonds Dec 2032 Term Corporate ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares iBonds Dec 2032 Term Corporate ETF and related companies with MarketBeat.com's FREE daily email newsletter.
